Navigation Links
Cambridge Semantics to Present on Smart Data and Competitive Intelligence Informatics at 2013 Pharma CI Conference & Exposition
Date:8/22/2013

BOSTON (PRWEB) August 22, 2013

Cambridge Semantics, leading provider of smart data solutions for the pharmaceutical industry, today announced its participation in the 2013 Pharma CI Conference & Exposition. Lee Feigenbaum, Vice President of Marketing and Technology for Cambridge Semantics, will present on pharma competitive intelligence (CI) solutions to automate data gathering, investigation and analytics to conference delegates. In addition, Cambridge Semantics is exhibiting at the conference.

When:
September 18, 2013
9:00 a.m. – 9:35 a.m.

Where:
Pharma CI Conference & Exhibition
Hilton East Brunswick Hotel
3 Tower Center Blvd.
East Brunswick, New Jersey 08816

Details: Large pharmaceutical organizations, like companies in many industries, face challenges with enterprise data management and end user data consumption. At Pharma CI Conference & Exposition, Feigenbaum’s presentation will introduce the concept of “CI Informatics,” technology solutions dedicated to gathering and distributing high-quality competitive intelligence information. Feigenbaum’s presentation will provide examples of CI Informatics in use based on Cambridge Semantics’ award-winning Anzo Pharma Competitive Intelligence solution.

Using semantic technology, Anzo proactively gathers and routes relevant and targeted CI information to the right people at the right time, from the right information sources – whether internal or external to the company, structured or unstructured. The software can be used for intelligence gathering across a number of use cases, including compound licensing, biopartnering, market intelligence, comparative effectiveness research, drug repositioning, self-service competitive intelligence reporting and analytics, and more.

Cambridge Semantics’ Anzo platform has been deployed by R&D CI teams, business development and sourcing teams, marketing groups and knowledge management teams at a number of leading pharma companies, including Merck, Lilly, Novartis, Biogen and others.

Media and analysts interested in a briefing with Cambridge Semantics, please contact Lora Friedrichsen at Cambridge(at)globalresultspr(dot)com or +1 949 608 0276.

About Cambridge Semantics

Cambridge Semantics is privately held and based in Boston, Massachusetts. For more information visit http://www.cambridgesemantics.com or follow us on Twitter @CamSemantics or Facebook.

Read the full story at http://www.prweb.com/releases/2013/8/prweb11051384.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. BioMed Realty Acquires 320 Charles In Cambridge, MA
2. Cambridge Semantics to Highlight Innovations in Drug Safety and Business Development at DIA 2013
3. Cambridge Semantics Underscores Need for Smart Data during “Data Demonstration Day” on Capitol Hill
4. Cambridge Semantics Wins SIIA Software CODiE Award for Best Business Intelligence and Analytics Solution
5. Industry Leader Linguamatics Hosts Record-breaking Spring Users Conference in Cambridge, UK
6. Cambridge Semantics to Present the Case for Unified Information Access at Enterprise Data World 2013
7. Cambridge College School of Management Program Hosts a Panel Discussion On Trends and Opportunities In Health Information Technology
8. Cambridge Semantics to Speak at 2013 Bio-IT World Conference & Expo
9. Cambridge Semantics Named 2013 SIIA CODiE Award Finalist
10. P&P Optica Invited to Cambridge Innovation Centre for the Canadian Technology Accelerator Program, One of Eight Canadian Life Science Companies Chosen to Participate
11. H3 Biomedicine Expands Cambridge Facilities, Doubles Employee Base as Scientific Program Advances
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/24/2017)... and ROCKVILLE, Md. , March ... of Maxwell Biotech Venture Fund (MBVF), today announced positive ... added to the standard drug therapy regimen in patients ... small molecule drug discovered by scientists at Sequella, Inc. ... Institutes of Health. A total of ...
(Date:3/24/2017)... 2017 Agenus Inc. (NASDAQ: AGEN), an immuno-oncology ... cancer vaccines, today announced participation at the following conferences: ... Blair and Maidstone Life Sciences conference "Cancer Immunotherapy Conference" ... New York, NY . Agenus will participate ... 9:40 am: Robert B. Stein , M.D., Ph.D., ...
(Date:3/23/2017)... 23, 2017  SeraCare Life Sciences, Inc., a ... vitro diagnostics manufacturers and clinical laboratories, is ... multiplexed Inherited Cancer reference material ... next-generation sequencing (NGS). The Seraseq™ Inherited Cancer DNA ... from industry experts to validate the ability ...
(Date:3/23/2017)... YORK , March 23, 2017 ... ... of death, putting significant strain on health care systems, in ... cancer diagnoses rises, so too does the development of innovative ... minimum side effects. Among the many types of cancer treatments, ...
Breaking Biology Technology:
(Date:2/28/2017)... Germany , February 28, 2017 News ... ... Amsterdam from 14 to 16 March, Materna ... destination, and show how seamless travel is a real benefit for ... has added biometrics to their passenger touch point solutions to take ...
(Date:2/22/2017)... 2017 With the biometrics market to ... four technologies that innovative and agile startups must ... in the changing competitive landscape: multifactor authentication (MFA), ... "Companies can no longer afford to ... Dimitrios Pavlakis , Industry Analyst at ABI ...
(Date:2/13/2017)... , Feb. 13, 2017  RSA Conference -- ... platform that is designed to enhance fraud detection ... release in the RSA Fraud & Risk Intelligence ... organizations to leverage additional insights from internal and ... to better protect their customers from targeted cybercrime ...
Breaking Biology News(10 mins):